Literature DB >> 6941908

Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy.

P Parker, I Burr, A Slonim, F K Ghishan, H Greene.   

Abstract

Individuals with type Ia glycogen storage disease (glucose-6-phosphatase deficiency) frequently develop hepatic adenomas. Potential complications involving these adenomas include malignant transformation and hemorrhage. Five of 9 patients with this disease had evidence of hepatic filling defects on radionucleotide liver scan when first evaluated at our hospital. Dietary therapy aimed at preventing hypoglycemia was begun in 7 of the 9 patients. Prevention of hypoglycemia resulted in the correction of all of the metabolic abnormalities (lactic acidosis, hyperlipidemia, hyperuricemia, and growth retardation). Treatment also corrected the marked elevation in plasma glucagon concentrations. A disappearance of the hepatic lesions occurred in 2 of the treated patients, and a marked reduction in size of the adenoma occurred in the third patient. The hepatic filling defects remained present in the two untreated patients. None of the affected patients receiving dietary therapy have developed hepatic adenomas. One of these patients is now 22 yr old and has received dietary therapy for 7 yr. Early dietary therapy seems to be effective in preventing development of adenomas as well as inducing their resolution.

Entities:  

Mesh:

Year:  1981        PMID: 6941908

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  21 in total

1.  Perioperative management of hemostasis for surgery of benign hepatic adenomas in patients with glycogen storage disease type ia.

Authors:  Alix Mollet-Boudjemline; Aurélie Hubert-Buron; Catherine Boyer-Neumann; Roxana Aldea; Dominique Franco; Pascale Trioche-Eberschweiller; Anne-Elisabeth Mas; Mylène Mabille; Philippe Labrune; Vincent Gajdos
Journal:  JIMD Rep       Date:  2011-06-22

Review 2.  Glycogen storage disease: recommendations for treatment.

Authors:  J Fernandes; J V Leonard; S W Moses; M Odièvre; M di Rocco; J Schaub; G P Smit; K Ullrich; P Durand
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

Review 3.  Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?

Authors:  Erin Demo; Donald Frush; Marcia Gottfried; John Koepke; Anne Boney; Deeksha Bali; Y T Chen; Priya S Kishnani
Journal:  J Hepatol       Date:  2006-11-09       Impact factor: 25.083

Review 4.  Management of hepatic adenomatosis.

Authors:  Manish Thapar; Oleg Grapp; Constantine Fisher
Journal:  Curr Gastroenterol Rep       Date:  2015-03

5.  Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit.

Authors:  T Leese; O Farges; H Bismuth
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

6.  Focal fatty liver change in glycogenosis type 1 A.

Authors:  P J Lee; J V Leonard; C Dicks-Mireaux
Journal:  Eur J Pediatr       Date:  1995-04       Impact factor: 3.183

7.  Biochemical evidence for the requirement of continuous glucose therapy in young adults with type 1 glycogen storage disease.

Authors:  J I Wolfsdorf; J F Crigler
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

8.  Liver cell adenoma showing sequential alteration of radiological findings suggestive of well-differentiated hepatocellular carcinoma.

Authors:  Takayuki Kogure; Yoshiyuki Ueno; Satoshi Sekiguchi; Kazuyuki Ishida; Takehiko Igarashi; Yuta Wakui; Takao Iwasaki; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

9.  Liver adenomas in glycogen storage disease in children. Ultrasound and angiographic study.

Authors:  F Brunelle; S Tammam; M Odievre; P Chaumont
Journal:  Pediatr Radiol       Date:  1984

Review 10.  Benign liver tumors in pediatric patients - Review with emphasis on imaging features.

Authors:  Liliana Chiorean; Xin-Wu Cui; Andrea Tannapfel; Doris Franke; Martin Stenzel; Wojciech Kosiak; Dagmar Schreiber-Dietrich; Jörg Jüngert; Jian-Min Chang; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.